A Prospective Randomized Multicentre Study to Compare Crinone 8% Once Daily Versus Other Vaginal Progesterone.

• Status: Unknown status
• Trial end date: 2008-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

To compare the effect of Crinone 8% administered once daily versus other vaginal progesterone in terms of ongoing pregnancy rate 5 weeks after embryo transfer as well as patient convenience.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Nordica Fertility Clinic
• Collaborator: Merck Serono International SA
• Treatments: Progesterone

Criteria

Inclusion Criteria:

• 18-40 years

• Regular menstrual cyclus 25-35 days

• both ovaries present

• No more than 2 previous IVF attempts

• Have given written informed consent

Exclusion Criteria:

• More than 2 previous attempts

• Known drug abuse

• Known allergies to the study medication

• No embryo transfer performed in the study cycle

• Previous participating in the study